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Abstract
Introduction:  We wish to report on a rare cause of dysphagia; oculopharyngeal muscular
dystrophy (OPMD). It is a late adult onset autosomal dominant form of muscular dystrophy that
constitutes as a rare diagnosis for any place outside of Canada and first case in southern Germany.
Case presentation: We report the medical odyssey of a 57-year old male Caucasian patient. He
was referred at our hospital for further clarification of a progressive dysphagia, which, at first view,
was thought to be tumor related due to the patient's typical anamnesis.
Conclusion: The present report outlines the importance of considering this rare disease for
general medicine practitioners as well as head and neck specialists as a differential diagnosis for
swallowing disorders with, even at second view, uncertain cause.
Case presentation
A 57-year old Caucasian male patient with acute pneumo-
nia and a progressive dysphagia was referred to our
department. He reported episodes of painless swallowing
difficulties, associated with xerostomia, hoarseness and
an uncomfortable sensation of a mass in the upper
esophagus. His general medical condition includes type II
diabetes, chronic bronchitis, chronic gastritis, urate neph-
ropathy with a history of nephrolithiasis and coronary
artery disease. The patient reported daily alcohol and nic-
otine abuse over a period of 40 years.
On physical examination he showed a distinct bilateral
eyelid ptosis combined with a mild facial weakness. Wet
voice and an insufficient cough reflex after solid and liq-
uid intake followed by consecutive aspiration were
observed. Laryngoscopy showed an incomplete glottic
closure and impaired vocal cord mobility. Video-radio-
logical barium examination revealed intra- and- postdegl-
utive aspiration (Figure 1). Contrast enhanced CT scans
showed an unclear homogeneous mass (1.5 × 2 cm)
located in the preepiglottic space, dorsal to the hyoid
bone.
We performed a panendoscopy under general anesthesia
and esophagus-gastroscopy, suspecting a malignant proc-
ess. Endoscopic findings neither confirmed a tumorous
process nor revealed any other obvious cause for the pro-
gressive dysphagia. Therefore a deep incision biopsy of
the preepiglottic space was performed, but no suspect
structures other than fat tissue were noted. Histopatholog-
ical evaluation of the preepiglottic mass confirmed solely
fatty tissue without malignant pathology.
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Family history revealed that he has eight siblings, four of
which developed similar symptoms at around 50 years of
age. One brother has only mild dysphagia. Furthermore
the patient's father, one paternal uncle, one paternal aunt
and her son suffer from dysphagia and eyelid ptosis. (Fig-
ure 2) The patient's family is native German without
French-Canadian or Jewish roots. The patient underwent
bilateral blepharoplasty surgery to correct eyelid ptosis
one year ago.
Considering the family history of swallowing disorders,
we suspected a hereditary cause of the dysphagia and ini-
tiated genetic counseling. DNA testing revealed a hetero-
zygous (GCG)10 expansion of the (GCG)-mini-repeat,
located in exon 1 of the poly(A) binding protein, nuclear
1gene (PABPN1), thus verifying oculopharyngeal muscu-
lar dystrophy (Figure 3).
After the diagnosis was confirmed and therapeutic
options were discussed, the patient refused a cricopharyn-
geal myotomy. Therefore a percutaneous endoscopic gas-
trostomy (PEG) placement was carried out to improve the
overall nutritional situation. After a period of five months,
he reported on unsteady functional improvements of his
swallowing. Other neurological functions remained
unchanged. The PEG probe was left in place since suffi-
cient oral deglutition did not occur.
Discussion and conclusion
Patients suffering from multiple ailments are common in
ENT hospitals and many exhibit dysphagia at some point.
Especially in patients with long periods of alcohol and
nicotine abuse, dysphagia is mostly related to malignant
processes of the hypopharynx, larynx or esophagus. This
patients underwent a series of hospitalizations simply
because physicians would not think of a disease as rare as
OPMD as a cause for dysphagia in Germany.
Most cases and families suffering from OPMD are located
in Canada [1] among the Bukhara Jewish community [2]
originating from Uzbekistan. For any place other than
Canada, where the largest cluster of OPMD cases is found
in the Province of Quebec (incidence 1:1000), this disease
is uncommon and almost always unfamiliar to head and
neck specialists or neurologists. OPMD was first described
in 1915 and in 1962 it was referred to as OPMD. Recent
studies were able to show that OPMD cases in Canada can
be traced back to a small group of French immigrants [3].
To date OPMD has been reported in over 20 countries
with an incidence so low; it has not yet been appraised
[3,4].
Video-radiological barium examination with intra- and- post- deglutive aspiration Figure 1
Video-radiological barium examination with intra- 
and- postdeglutive aspiration. From left to right: Oral 
phase of the swallowing procedure (left picture), laryngeal 
phase of the swallowing procedure (middle picture) and pro-
longed laryngeal/pharyngeal phase (right picture) with aspira-
tion into the larynx and trachea.
Pedigree of the patient (marked by arrow) indicating auto- somal-dominant transmission of OPMD Figure 2
Pedigree of the patient (marked by arrow) indicating 
autosomal-dominant transmission of OPMD. One 69 
year old brother (marked by a question mark) of the index 
patient was reported to have only mild dysphagia without 
eyelid ptosis which may reflect mild expression of the disease 
or even chance association. The affection status of the pater-
nal grandmother (marked by a question mark) is unclear 
because she died already at the age of 36 years.Cases Journal 2009, 2:94 http://www.casesjournal.com/content/2/1/94
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OPMD usually manifests in the 4th to 6th decade with
slowly progressive eyelid ptosis and dysphagia due to
impaired levator palpebrae and pharyngeal muscle func-
tion. In most cases the eyelid ptosis is the first symptom
and is almost always closely followed by a progressive
dysphagia. At a later stage and as the disease evolves,
extraocular and facial muscles may also become affected.
However, eyelid ptosis is generally recognized as the first
and cardinal symptom. In a minor percentage, patients
develop weakness and atrophy of the tongue, pelvic girdle
muscles and to a lesser extent the shoulder girdle muscles
[5].
The diagnosis can only be finalized by DNA testing of
CGC triplets. To date there is no causal treatment for this
disease. A high-protein diet is recommended for optimal
nutritional balance. Aspiration pneumonia, as in the
reported case, is a frequent complication; therefore, early
medical supervision should be sought. At this time, only
surgical treatments to correct the functional aspects of
OPMD is available [6]. Surgical correction of the ptosis
and a cricopharyngeal myotomy has been reported as
effective surgical treatment. Owing to symptomatic treat-
ment and alternative nutritional options, life expectancy
is not reduced by the condition. Data regarding the sur-
vival of untreated OPMD does not exist. Outside of Can-
ada, OPMD reports from neurologists are rare; from
otolaryngologists they are scarce and they have so far not
been made from general practitioners. In a time where
mobility and relocation is facilitated by air travel, exotic
diagnoses increase. Therefore it is important to have
OPMD in mind when often dealing with a large group of
patients suffering from dysphagia, as most head and neck
specialists do. Due to the rather unspecific nature of the
cardinal symptoms, after clinical diagnosis, a DNA test is
indicated to confirm the expansion of the GCG-mini
repeat in exon 1 of the PABPN1 gene.
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Analysis of GCG-repeat size in exon 1 of the PABPN1 gene  by PCR and denaturing PAA gel electrophoresis as described  previously showing heterozygosity for a (GCG)10 expansion  in the index patient (lane 5, arrow) Figure 3
Analysis of GCG-repeat size in exon 1 of the 
PABPN1 gene by PCR and denaturing PAA gel elec-
trophoresis as described previously showing hetero-
zygosity for a (GCG)10 expansion in the index 
patient (lane 5, arrow). Lanes 1, 3, 6, and 9 represent nor-
mal homozygous controls for the (GCG)6 allele. Lanes 2, 4, 7 
and 8 show heterozygote and non related carriers of 
(GCG)8, (GCG)9, (GCG)11, and (GCG)12 expansions, 
respectively.